Skip to main content
Year archive

Active Biotech — 2016 filings

All 40 regulatory filings released by Active Biotech (ACTI) in 2016, sourced directly from the official regulator.

40 Filings
2016 Period
2016 filings (40)
Filing Released Lang
Number of shares and votes in Active Biotech
Declaration of Voting Results & Voting Rights Announcements
2016-12-30 English
Antal aktier och röster i Active Biotech
Declaration of Voting Results & Voting Rights Announcements
2016-12-30 Swedish
Active Biotechs nyemission genomförd
Capital/Financing Update
2016-12-12 Swedish
Active Biotech's rights issue completed
Share Issue/Capital Change
2016-12-12 English
Active Biotechs valberedning utsedd
Board/Management Information
2016-11-22 Swedish
Active Biotech's election committee appointed
Governance Information
2016-11-22 English
Prospekt avseende Active Biotechs nyemission offentliggjort
Report Publication Announcement
2016-11-18 Swedish
Prospectus relating to Active Biotech's rights issue published
Capital/Financing Update
2016-11-18 English
Active Biotech carries out rights issue of approximately SEK 55 million
Capital/Financing Update
2016-11-11 English
Active Biotech genomför företrädesemission om cirka 55 miljoner kronor
Capital/Financing Update
2016-11-11 Swedish
Active Biotech och NeoTX ingår partnerskap för utveckling och kommersialisering av ANYARA för immunonkologi
Regulatory Filings
2016-10-26 Swedish
Active Biotech and NeoTX enter into a partnership for the development and commercialization of ANYARA for immuno-oncology
Regulatory Filings
2016-10-26 English
Active Biotech uppdaterar om utvecklingen av laquinimod: Special Protocol Assessment (SPA) för laquinimod upphävs efter diskussion med FDA
Regulatory Filings
2016-09-19 Swedish
Active Biotech update on laquinimod Development: The U.S, Food and Drug administration rescinds the Special Protocol Assessment for laquinimod
Regulatory Filings
2016-09-19 English
Interim / Quarterly Report 2016
Interim / Quarterly Report H1 2016
2016-08-11 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report H1 2016
2016-08-11 English
Active Biotech AB Delårsrapport januari - juni 2016
Interim / Quarterly Report H1 2016
2016-08-11 Swedish
Active Biotech AB Interim report January - June 2016
Interim / Quarterly Report H1 2016
2016-08-11 English
Annual General Meeting of Active Biotech AB
AGM Information
2016-05-27 English
Årsstämma i Active Biotech AB
AGM Information
2016-05-27 Swedish
Annual Report 2015
Annual Report FY 2015
2016-05-10 English
Annual Report 2015 Active Biotech AB (publ)
Report Publication Announcement
2016-04-29 English
Årsredovisning 2015 Active Biotech AB (publ)
Report Publication Announcement
2016-04-29 Swedish
Audit Report / Information 2015
Audit Report / Information FY 2015
2016-04-29 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report Q1 2016
2016-04-28 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report Q1 2016
2016-04-28 English
Active Biotech AB Delårsrapport januari - mars 2016
Interim / Quarterly Report Q1 2016
2016-04-28 Swedish
Active Biotech AB Interim report January - March 2016
Interim / Quarterly Report Q1 2016
2016-04-28 English
Active Biotech: Kallelse till årsstämma
AGM Information
2016-04-26 Swedish
Active Biotech: Notice of Annual General Meeting of Shareholders
AGM Information
2016-04-26 English
Active Biotech plans to develop tasquinimod for the treatment of multiple myeloma
Regulatory Filings
2016-03-23 English
Active Biotech planerar utveckling av tasquinimod för behandling av multipelt myelom
Regulatory Filings
2016-03-23 Swedish
Interim / Quarterly Report 2015
Interim / Quarterly Report FY 2015
2016-02-18 Swedish
Interim / Quarterly Report 2015
Interim / Quarterly Report FY 2015
2016-02-18 English
Active Biotech AB Year-end report January - December 2015
Interim / Quarterly Report FY 2015
2016-02-18 English
Active Biotech AB Bokslutsrapport januari - december 2015
Interim / Quarterly Report FY 2015
2016-02-18 Swedish
CORRECTION: Active Biotech: Information regarding the clinical study LEGATO-HD
Regulatory Filings
2016-01-11 English
CORRECTION: Active Biotech: Information om den kliniska studien LEGATO-HD
Regulatory Filings
2016-01-11 Swedish
Teva och Active Biotech meddelar att den högre dosgruppen med laquinimod avbryts i två multipel skleros-prövningar
Regulatory Filings
2016-01-04 Swedish
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials
Regulatory Filings
2016-01-04 English